Lipid composition influences the release of Alzheimer's amyloid β-peptide from membranes

被引:75
|
作者
Lemkul, Justin A. [1 ]
Bevan, David R. [1 ]
机构
[1] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA
基金
美国国家科学基金会;
关键词
simulation; amyloid; molecular dynamics; membrane; MOLECULAR-DYNAMICS SIMULATIONS; PARTICLE MESH EWALD; SOLID-STATE NMR; SECONDARY STRUCTURE; CONSTANT-TEMPERATURE; ENDOGENOUS SEED; GAMMA-SECRETASE; PROTEIN; DISEASE; GANGLIOSIDES;
D O I
10.1002/pro.678
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The behavior of the amyloid beta-peptide (A beta) within a membrane environment is integral to its toxicity and the progression of Alzheimer's disease. Ganglioside GM1 has been shown to enhance the aggregation of A beta, but the underlying mechanism is unknown. Using atomistic molecular dynamics simulations, we explored the interactions between the 40-residue alloform of A beta (A beta(40)) and several model membranes, including pure palmitoyloleoylphosphatidylcholine (POPC) and palmitoyloleoylphosphatidylserine (POPS), an equimolar mixture of POPC and palmitoyloleoylphosphatidylethanolamine (POPE), and lipid rafts, both with and without GM1, to understand the behavior of A beta(40) in various membrane microenvironments. A beta(40) remained inserted in POPC, POPS, POPC/POPE, and raft membranes, but in several instances exited the raft containing GM1. A beta(40) interacted with GM1 largely through hydrogen bonding, producing configurations containing beta-strands with C-termini that, in some cases, exited the membrane and became exposed to solvent. These observations provide insight into the release of A beta from the membrane, a previously uncharacterized process of the A beta aggregation pathway.
引用
收藏
页码:1530 / 1545
页数:16
相关论文
共 50 条
  • [31] Impairment of PMCA Activity by Amyloid β-Peptide in Membranes from Alzheimer's Disease-Affected Brain and from Other Model Systems
    Mata, Ana M.
    Berrocal, Maria
    Marcos, Daniel
    Rosario Sepulveda, M.
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 170A - 170A
  • [32] Amyloid β-Peptide and Alzheimer's Disease: It's All the RAGE
    Skaper, Stephen D.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (05) : 494 - 494
  • [33] Alzheimer's disease amyloid-β peptide analogue alters the ps-dynamics of phospholipid membranes
    Buchsteiner, Alexandra
    Hauss, Thomas
    Dante, Silvia
    Dencher, Norbert A.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2010, 1798 (10): : 1969 - 1976
  • [34] Peptid-tethered bilayer lipid membranes and their interaction with Amyloid β-peptide
    Song, Haipeng
    Sinner, Eva-Kathrin
    Knoll, Wolfgang
    BIOINTERPHASES, 2007, 2 (04) : 151 - 158
  • [35] Amyloid-β peptide disruption of lipid membranes and the effect of metal ions
    Lau, TL
    Ambroggio, EE
    Tew, DJ
    Cappai, R
    Masters, CL
    Fidelio, GD
    Barnham, KJ
    Separovic, F
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 356 (03) : 759 - 770
  • [36] Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's β-amyloid peptide
    Austen, Brian M.
    Paleologou, Katerina E.
    Ali, Sumaya A. E.
    Qureshi, Mohamed M.
    Allsop, David
    El-Agnaf, Omar M. A.
    BIOCHEMISTRY, 2008, 47 (07) : 1984 - 1992
  • [37] Alzheimer's disease, amyloid peptide and synaptic dysfunction
    Hemar, Agnes
    Mulle, Christophe
    M S-MEDECINE SCIENCES, 2011, 27 (8-9): : 733 - 736
  • [38] Molecular mechanism of Alzheimer's β-amyloid peptide aggregation
    Li, Yanyan
    Mao, Xiwen
    Liu, Keyu
    Niu, Zheng
    CHINESE SCIENCE BULLETIN-CHINESE, 2024, 69 (07): : 903 - 911
  • [39] Alzheimer's β-amyloid peptide:: affinity for metal chelates
    Balakrishnan, R
    Parthasarathy, R
    Sulkowski, E
    JOURNAL OF PEPTIDE RESEARCH, 1998, 51 (02): : 91 - 95
  • [40] Assembly of Alzheimer's Aβ peptide into nanostructured amyloid fibrils
    Morgado, Isabel
    Faendrich, Marcus
    CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2011, 16 (06) : 508 - 514